Your browser doesn't support javascript.
loading
Antibiotic use from formal and informal healthcare providers in the Democratic Republic of Congo: a population-based study in two health zones.
Ingelbeen, Brecht; Phanzu, Delphin M; Phoba, Marie-France; Budiongo, Mi Y N; Berhe, Neamin M; Kamba, Frédéric K; Kalonji, Lisette; Mbangi, Bijou; Hardy, Liselotte; Tack, Bieke; Im, Justin; Heyerdahl, Leonardo W; Da Luz, Raquel Inocencio; Bonten, Marc J M; Lunguya, Octavie; Jacobs, Jan; Mbala, Placide; van der Sande, Marianne A B.
Afiliação
  • Ingelbeen B; Institute of Tropical Medicine (ITM), Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: bingelbeen@itg.be.
  • Phanzu DM; Kimpese Health Research Center, Kimpese, Democratic Republic of Congo.
  • Phoba MF; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Budiongo MYN; Kimpese Health Research Center, Kimpese, Democratic Republic of Congo.
  • Berhe NM; Institute of Tropical Medicine (ITM), Antwerp, Belgium.
  • Kamba FK; Kimpese Health Research Center, Kimpese, Democratic Republic of Congo; Centre de Coordination, de Recherches et de documentation en Sciences Sociales desservant L'Afrique Subsaharienne (CERDAS), Faculté des Sciences Sociales, Administratives et Politiques, Université de Kinshasa, Kinshasa, Democrati
  • Kalonji L; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Mbangi B; Kimpese Health Research Center, Kimpese, Democratic Republic of Congo.
  • Hardy L; Institute of Tropical Medicine (ITM), Antwerp, Belgium.
  • Tack B; Institute of Tropical Medicine (ITM), Antwerp, Belgium.
  • Im J; International Vaccine Institute, Seoul, Republic of Korea.
  • Heyerdahl LW; Anthropology & Ecology of Disease Emergence Unit, Institut Pasteur, Paris, France.
  • Da Luz RI; Institute of Tropical Medicine (ITM), Antwerp, Belgium.
  • Bonten MJM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Lunguya O; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Jacobs J; Institute of Tropical Medicine (ITM), Antwerp, Belgium; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Mbala P; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
  • van der Sande MAB; Institute of Tropical Medicine (ITM), Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Clin Microbiol Infect ; 28(9): 1272-1277, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35447342
ABSTRACT

OBJECTIVE:

In the Democratic Republic of Congo and other low-resource countries, community-acquired pathogens are increasingly resistant to most locally available antibiotics. To guide efforts to optimize antibiotic use to limit antibiotic resistance, we quantified healthcare provider-specific and community-wide antibiotic use.

METHODS:

From household surveys, we estimated monthly healthcare visit rates by provider. From healthcare visit exit surveys, we estimated prevalence, defined daily doses, and access/watch/reserve distribution of antibiotic use by provider. Combining both, we estimated community-wide antibiotic use rates.

RESULTS:

Of 88.7 (95% CI 81.9-95.4) healthcare visits per 1000 person-months (n = 31221), visits to private clinics (31.0, 95% CI 30.0-32.0) and primary health centres (25.5, 95% CI 24.6-26.4) were most frequent. Antibiotics were used during 64.3% (95% CI 55.2-73.5%, 162/224) of visits to private clinics, 51.1% (95% CI 45.1-57.2%, 245/469) to health centres, and 48.8% (95% CI 44.4-53.2%, 344/454) to medicine stores. Antibiotic defined daily doses per 1000 inhabitants per day varied between 1.75 (95% CI 1.02-2.39) in rural Kimpese and 10.2 (95% CI 6.00-15.4) in (peri) urban Kisantu, mostly explained by differences in healthcare utilisation (respectively 27.8 versus 105 visits per 1000 person-months), in particular of private clinics (1.23 versus 38.6 visits) where antibiotic use is more frequent. The fraction of Watch antibiotics was 30.3% (95% CI 24.6-35.9%) in private clinics, 25.6% (95% CI 20.2-31.1%) in medicine stores, and 25.1% (95% CI 19.0-31.2%) in health centres. Treatment durations <3 days were more frequent at private clinics (5.3%, 9/169) and medicine stores (4.1%, 14/338) than at primary health centres (1.8%, 5/277).

DISCUSSION:

Private healthcare providers, ubiquitous in peri-urban settings, contributed most to community-wide antibiotic use and more frequently dispensed Watch antibiotics and shortened antibiotic courses. Efforts to optimize antibiotic use should include private providers at community level.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoal de Saúde / Antibacterianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoal de Saúde / Antibacterianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article